Homology Medicines, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Homology Medicines, Inc.
CIK #0001661998
EDGAR Form CIK 2011 - 2026
10-K [0001661998]
10-Q [0001661998]
3 [0001661998]
4 [0001661998]
8-K [0001661998]
D [0001661998]
SC 13D [0001661998]
SC 13G [0001661998]
Form 13D/13G Filer Form 13D/13G Subject Filed
Boxer Capital Management LLC Q32 Bio Inc [2026-07-10]
Biotechnology Value Fund L P Q32 Bio Inc [2026-06-04]
RA Capital Management LP Q32 Bio Inc [2026-06-04]
Sirenia Capital Management LP Q32 Bio Inc [2026-05-15]
Opaleye Management Inc Q32 Bio Inc [2026-02-20]
Point72 Asset Management LP Q32 Bio Inc [2026-02-19]
SIO Capital Management LLC Q32 Bio Inc [2025-04-08]
SIO Capital Management LLC Q32 Bio Inc [2025-02-10]
Bristol Myers Squibb Co Q32 Bio Inc [2024-11-13]
Acorn BioVentures LP Q32 Bio Inc [2024-04-04]
View All
Form 3/4/5 Subject 2011 - 2026
Manke Isaac
Q32 Bio Inc.
Laporte Kathleen
Iwicki Mark T
Tzianabos Arthur
Grayzel David S
Thistle Mary
Xu Diyong
Lundberg Sven Ante
Atlas Venture Opportunity Fund Ill, L.P.
View All
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com